Make scientific figures in minutes

Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software

search icon
arrow-right
Use Icons In The App

Try a synonym, or sign up to request an icon from the app.

Icon Library
 > 
Cell Types
 > 
Muscle Cells
 > 
Myoepithelial cell

Myoepithelial cell

Myoepithelial cell - Editable icon of Myoepithelial cell
[{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc440e/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc440e/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc440d/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc440d/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc440c/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc440c/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc440b/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc440b/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc440a/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc440a/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4409/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4409/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4408/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4408/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4407/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4407/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4406/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4406/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4405/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4405/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4404/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4404/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4403/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4403/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4402/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4402/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4401/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4401/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f5d2e4d6c910004dc4400/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f5d2e4d6c910004dc4400/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350a4/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350a4/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350a5/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350a5/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350a6/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350a6/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350a7/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350a7/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350a8/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350a8/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350a9/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350a9/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350aa/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350aa/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350ab/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350ab/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350ac/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350ac/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350ad/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350ad/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350ae/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350ae/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350af/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350af/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b0/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b0/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b1/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b1/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b2/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b2/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b3/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b3/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b4/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b4/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b5/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b5/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b6/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b6/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b7/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b7/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b8/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b8/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350b9/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350b9/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350ba/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350ba/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350bb/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350bb/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350bc/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350bc/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350bd/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350bd/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350be/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350be/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350bf/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350bf/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c0/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c0/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c1/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c1/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c2/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c2/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c3/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c3/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c4/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c4/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c5/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c5/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c6/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c6/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c7/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c7/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c8/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c8/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350c9/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350c9/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350ca/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350ca/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350cb/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350cb/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350cc/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350cc/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350cd/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350cd/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350ce/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350ce/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350cf/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350cf/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350d0/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350d0/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350d1/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350d1/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350d2/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350d2/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350d3/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350d3/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350d4/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350d4/5d3f5cbf4d6c910004dc43ff.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9f2323ccf015b9bb350d5/5d3f5cbf4d6c910004dc43ff.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9f2323ccf015b9bb350d5/5d3f5cbf4d6c910004dc43ff.png"}]
Keywords
keyword text
gland,duct,mammary,breast,myoepithelial cell,myoepithelium,myoepithelia
Image types

Myoepithelial cell icon JPEG

Myoepithelial cell icon PNG

Myoepithelial cell icon SVG

Myoepithelial cell icon GIF

compliance icon

BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More

More Icons like this one in
Muscle Cells
Enterocyte (epithelial–mesenchymal transition, stage 4)
Enterocyte (epithelial–mesenchymal transition, stage 4)
Enterocyte (epithelial–mesenchymal transition, stage 2)
Enterocyte (epithelial–mesenchymal transition, stage 2)
Enterocyte (epithelial–mesenchymal transition, stage 0)
Enterocyte (epithelial–mesenchymal transition, stage 0)
Enterocyte (epithelial–mesenchymal transition, stage 3)
Enterocyte (epithelial–mesenchymal transition, stage 3)
Enterocyte (epithelial–mesenchymal transition, stage 1)
Enterocyte (epithelial–mesenchymal transition, stage 1)
L-cell (releasing GLP-1, schematic)
L-cell (releasing GLP-1, schematic)
L-cell (releasing GLP-1)
L-cell (releasing GLP-1)
L-cell
L-cell
Cardiac endothelial cell
Cardiac endothelial cell
Cardiomyocyte (wavy, binucleated)
Cardiomyocyte (wavy, binucleated)
Cardiomyocyte (wavy, binucleated, branch)
Cardiomyocyte (wavy, binucleated, branch)
Cardiomyocyte (branched, hypertrophy)
Cardiomyocyte (branched, hypertrophy)
Enterocyte (epithelial–mesenchymal transition, stage 4)
Enterocyte (epithelial–mesenchymal transition, stage 4)
Enterocyte (epithelial–mesenchymal transition, stage 2)
Enterocyte (epithelial–mesenchymal transition, stage 2)
Enterocyte (epithelial–mesenchymal transition, stage 0)
Enterocyte (epithelial–mesenchymal transition, stage 0)
Enterocyte (epithelial–mesenchymal transition, stage 3)
Enterocyte (epithelial–mesenchymal transition, stage 3)
Enterocyte (epithelial–mesenchymal transition, stage 1)
Enterocyte (epithelial–mesenchymal transition, stage 1)
L-cell (releasing GLP-1, schematic)
L-cell (releasing GLP-1, schematic)
L-cell (releasing GLP-1)
L-cell (releasing GLP-1)
L-cell
L-cell
Cardiac endothelial cell
Cardiac endothelial cell
Cardiomyocyte (wavy, binucleated)
Cardiomyocyte (wavy, binucleated)
Cardiomyocyte (wavy, binucleated, branch)
Cardiomyocyte (wavy, binucleated, branch)
Cardiomyocyte (branched, hypertrophy)
Cardiomyocyte (branched, hypertrophy)
Related Categories
Agriculture
Agricultural Symbols
Agriculture
Equipment and Objects
Agriculture
Animal Agriculture
Agriculture
Landscapes and Soil
Agriculture
Plant Pathology
Agriculture
Plant Anatomy
Agriculture
Produce
Agriculture
Agricultural Plants
Graphs and Symbols
Symbols & Signs
Graphs and Symbols
Callouts and Banners
Graphs and Symbols
Lists and Numbers
Graphs and Symbols
Graph Icons
Epithelium
Glandular Epithelia
Species
Reptiles
Lab and Objects
Food
Human Anatomy
Dental
Lab and Objects
Chemistry
Nanoparticles
Lipids and Carbs
Glycans
Nucleic Acids
Nucleic acid motifs
Cell Structures
Cytoskeleton and ECM
Epithelium
Skin Epithelia
Lab and Objects
Machinery and Tech
Lab and Objects
Animal Housing
Lab and Objects
Microscope and Optics
Lab and Objects
Tools
Lab and Objects
Wells, Plates, and Cultures
Lab and Objects
Tubes and Vials
Lab and Objects
Beakers, Bottles, Flasks
Epithelium
Intestinal Epithelia
Species
Rodents
Species
Amphibians
Nucleic Acids
Nucleotide Bases
Nucleic Acids
DNA (with Nucleotides)
Nucleic Acids
RNA
Nucleic Acids
DNA Ministring
Nucleic Acids
Plasmids
Nucleic Acids
DNA
Membranes
Phospholipid Bilayer Membranes
Membranes
Nuclear Membranes
Membranes
Simplified Bilayer Membranes
Proteins
Intercellular Proteins
Proteins
Generic Proteins
Human Anatomy
Embryology
Human Anatomy
Skin
Human Anatomy
Endocrine and Exocrine System
Human Anatomy
Reproductive System
Human Anatomy
Urogenital System
Human Anatomy
Digestive System
Human Anatomy
Respiratory System
Human Anatomy
Head and Neuroanatomy
Human Anatomy
Lymphatic System
Human Anatomy
Cardiovascular System
Human Anatomy
Skeletal System
Human Anatomy
Muscular System
Human Anatomy
Human Figure
Lab and Objects
Environment and Ecology
Lab and Objects
Other Items
Lipids and Carbs
Carbohydrates
Membranes
Bacterial Membranes
Membranes
Neural Membranes
Proteins
Soluble Proteins
Proteins
Enzymes
Proteins
Antibodies
Proteins
Receptors and Ligands
Cell Types
Plant Cells
Cell Types
Neural Cells
Cell Types
Reproductive Cells
Cell Types
Muscle Cells
Cell Types
Secretory Cells
Cell Types
Epithelial Cells
Cell Types
Stromal Cells
Cell Types
Immune & Blood Cells
Cell Types
Generic Cells
Cell Types
Mitosis and Meiosis
Species
Other Organisms
Lab and Objects
Medical Equipment
Species
Fungi
Proteins
Transporters
Species
Birds
Chemistry
Biochemistry
Species
Bacteria
Species
Viruses
Species
Plants
Species
Mammals
Chemistry
Structural Formulas
Chemistry
Molecular Model Kit
Species
Fish
Species
Arthropods
Lipids and Carbs
Lipids
Species
Worms
Cell Structures
Organelles
Back To Library Home

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today

Sign Up Free

FAQs

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Myoepithelial cell icon along with our library of more than 30,000 life science icons.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Myoepithelial cell is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Myoepithelial cell icon customizable in BioRender?

Most icons in BioRender, including the Myoepithelial cell icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

How are scientists using the Myoepithelial cell icon in their work?

BioRender users often use the Myoepithelial cell icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

Can I export figures that include the Myoepithelial cell icon for publication or presentations?

Yes, figures containing the Myoepithelial cell icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Is the Myoepithelial cell icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Myoepithelial cell icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender uses cookies to improve our user experience. By continuing to our site, you agree to our use of cookies outlined in our Privacy Policy.
Agree

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon